{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:05:12Z","timestamp":1779289512708,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Heilongjiang Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["LH2022H017"],"award-info":[{"award-number":["LH2022H017"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fundamental Research Funds for the Provincial Universities","award":["JFYWH202003"],"award-info":[{"award-number":["JFYWH202003"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473911"],"award-info":[{"award-number":["82473911"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10557-025-07677-2","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:39:23Z","timestamp":1740029963000},"page":"107-125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Biochanin A Mitigates Pressure Overload-Induced Cardiac Hypertrophy Through Modulation of the NF-\u03baB\/Cbl-b\/NLRP3 Signaling Axis"],"prefix":"10.1007","volume":"40","author":[{"given":"Lina","family":"Ba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhichao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3802-4409","authenticated-orcid":false,"given":"Hanping","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"issue":"2","key":"7677_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41440-022-01119-4","volume":"46","author":"K Kida","year":"2023","unstructured":"Kida K. Left ventricular hypertrophy was not built in a day. Hypertens Res. 2023;46(2):341\u20132. https:\/\/doi.org\/10.1038\/s41440-022-01119-4","journal-title":"Hypertens Res"},{"key":"7677_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2023.107230","volume":"153","author":"M Volpe","year":"2023","unstructured":"Volpe M, Gallo G. Hypertension, coronary artery disease and myocardial ischemic syndromes. Vascul Pharmacol. 2023;153: 107230. https:\/\/doi.org\/10.1016\/j.vph.2023.107230","journal-title":"Vascul Pharmacol"},{"issue":"7","key":"7677_CR3","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/eurheartj\/ehac672","volume":"44","author":"X Zhang","year":"2023","unstructured":"Zhang X, Cai J, Li X, Chen X, Zhang Q. Left ventricular hypertrophy with cardiomyocyte atrophy and extensive interstitial fibrosis: a mitochondrial cardiomyopathy. Eur Heart J. 2023;44(7):627. https:\/\/doi.org\/10.1093\/eurheartj\/ehac672","journal-title":"Eur Heart J"},{"key":"7677_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.yjmcc.2019.01.005","volume":"129","author":"Y Liu","year":"2019","unstructured":"Liu Y, Lu H, Zhang C, Hu J, Xu D. Recent advances in understanding the roles of T cells in pressure overload-induced cardiac hypertrophy and remodeling. J Mol Cell Cardiol. 2019;129:293\u2013302. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.01.005","journal-title":"J Mol Cell Cardiol"},{"key":"7677_CR5","doi-asserted-by":"publisher","unstructured":"Tang X, Wang P, Zhang R et al. KLF2 regulates neutrophil activation and thrombosis in cardiac hypertrophy and heart failure progression. J Clin Invest. 2022;132(3). https:\/\/doi.org\/10.1172\/JCI147191.","DOI":"10.1172\/JCI147191"},{"issue":"2","key":"7677_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s10741-021-10134-5","volume":"27","author":"G Giamouzis","year":"2022","unstructured":"Giamouzis G, Dimos A, Xanthopoulos A, Skoularigis J, Triposkiadis F. Left ventricular hypertrophy and sudden cardiac death. Heart Fail Rev. 2022;27(2):711\u201324. https:\/\/doi.org\/10.1007\/s10741-021-10134-5","journal-title":"Heart Fail Rev"},{"key":"7677_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109595","volume":"121","author":"Y Fang","year":"2020","unstructured":"Fang Y, Tian S, Pan Y, et al. Pyroptosis: a new frontier in cancer. Biomed Pharmacother. 2020;121:109595. https:\/\/doi.org\/10.1016\/j.biopha.2019.109595","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"7677_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41569-023-00946-3","volume":"21","author":"S Toldo","year":"2024","unstructured":"Toldo S, Abbate A. The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases. Nat Rev Cardiol. 2024;21(4):219\u201337. https:\/\/doi.org\/10.1038\/s41569-023-00946-3","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"7677_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41392-023-01687-y","volume":"9","author":"J Yao","year":"2024","unstructured":"Yao J, Sterling K, Wang Z, Zhang Y, Song W. The role of inflammasomes in human diseases and their potential as therapeutic targets. Signal Transduct Target Ther. 2024;9(1):10. https:\/\/doi.org\/10.1038\/s41392-023-01687-y","journal-title":"Signal Transduct Target Ther"},{"key":"7677_CR10","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","volume":"67","author":"S Wang","year":"2019","unstructured":"Wang S, Yuan YH, Chen NH, Wang HB. The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in Parkinson\u2019s disease. Int Immunopharmacol. 2019;67:458\u201364. https:\/\/doi.org\/10.1016\/j.intimp.2018.12.019","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"7677_CR11","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41419-019-2157-1","volume":"10","author":"X Chen","year":"2019","unstructured":"Chen X, Liu G, Yuan Y, et al. NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-kappaB signaling. Cell Death Dis. 2019;10(12):906. https:\/\/doi.org\/10.1038\/s41419-019-2157-1","journal-title":"Cell Death Dis"},{"issue":"9","key":"7677_CR12","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41419-020-02985-x","volume":"11","author":"B Bai","year":"2020","unstructured":"Bai B, Yang Y, Wang Q, et al. NLRP3 inflammasome in endothelial dysfunction. Cell Death Dis. 2020;11(9):776. https:\/\/doi.org\/10.1038\/s41419-020-02985-x","journal-title":"Cell Death Dis"},{"key":"7677_CR13","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2021.27","volume":"23","author":"Y Zuo","year":"2021","unstructured":"Zuo Y, Chen L, Gu H, et al. GSDMD-mediated pyroptosis: a critical mechanism of diabetic nephropathy. Expert Rev Mol Med. 2021;23: e23. https:\/\/doi.org\/10.1017\/erm.2021.27","journal-title":"Expert Rev Mol Med"},{"issue":"1","key":"7677_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.apsb.2022.08.007","volume":"13","author":"P Yanpiset","year":"2023","unstructured":"Yanpiset P, Maneechote C, Sriwichaiin S, et al. Gasdermin D-mediated pyroptosis in myocardial ischemia and reperfusion injury: cumulative evidence for future cardioprotective strategies. Acta Pharm Sin B. 2023;13(1):29\u201353. https:\/\/doi.org\/10.1016\/j.apsb.2022.08.007","journal-title":"Acta Pharm Sin B"},{"key":"7677_CR15","doi-asserted-by":"publisher","unstructured":"De Miguel C, Pelegrin P, Baroja-Mazo A, Cuevas S. Emerging role of the inflammasome and pyroptosis in hypertension. Int J Mol Sci. 2021;22(3). https:\/\/doi.org\/10.3390\/ijms22031064","DOI":"10.3390\/ijms22031064"},{"key":"7677_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.709703","volume":"12","author":"J Wu","year":"2021","unstructured":"Wu J, Dong E, Zhang Y, Xiao H. The role of the inflammasome in heart failure. Front Physiol. 2021;12:709703. https:\/\/doi.org\/10.3389\/fphys.2021.709703.","journal-title":"Front Physiol"},{"key":"7677_CR17","doi-asserted-by":"crossref","unstructured":"Bai Y, Sun X, Chu Q et al. Caspase-1 regulate AngII-induced cardiomyocyte hypertrophy via upregulation of IL-1beta. Biosci Rep. 2018;38(2). https:\/\/doi.org\/10.1042\/BSR20171438","DOI":"10.1042\/BSR20171438"},{"issue":"1","key":"7677_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.acthis.2020.151653","volume":"123","author":"YF Zhu","year":"2021","unstructured":"Zhu YF, Wang R, Chen W, et al. miR-133a-3p attenuates cardiomyocyte hypertrophy through inhibiting pyroptosis activation by targeting IKKepsilon. Acta Histochem. 2021;123(1):151653. https:\/\/doi.org\/10.1016\/j.acthis.2020.151653","journal-title":"Acta Histochem"},{"issue":"3","key":"7677_CR19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1210\/jcem.84.3.5561","volume":"84","author":"PJ Nestel","year":"1999","unstructured":"Nestel PJ, Pomeroy S, Kay S, et al. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab. 1999;84(3):895\u20138. https:\/\/doi.org\/10.1210\/jcem.84.3.5561","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"7677_CR20","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1142\/S0192415X21500750","volume":"49","author":"J Yan","year":"2021","unstructured":"Yan J, Qiu P, Zhang X, et al. Biochanin A from Chinese medicine: an isoflavone with diverse pharmacological properties. Am J Chin Med. 2021;49(7):1623\u201343. https:\/\/doi.org\/10.1142\/S0192415X21500750","journal-title":"Am J Chin Med"},{"key":"7677_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2020.137907","volume":"722","author":"A Sarfraz","year":"2020","unstructured":"Sarfraz A, Javeed M, Shah MA, et al. Biochanin A: a novel bioactive multifunctional compound from nature. Sci Total Environ. 2020;722: 137907. https:\/\/doi.org\/10.1016\/j.scitotenv.2020.137907","journal-title":"Sci Total Environ"},{"key":"7677_CR22","doi-asserted-by":"publisher","first-page":"8965047","DOI":"10.1155\/2020\/8965047","volume":"2020","author":"XH Yu","year":"2020","unstructured":"Yu XH, Chen JJ, Deng WY, et al. Biochanin A mitigates atherosclerosis by inhibiting lipid accumulation and inflammatory response. Oxid Med Cell Longev. 2020;2020:8965047. https:\/\/doi.org\/10.1155\/2020\/8965047","journal-title":"Oxid Med Cell Longev"},{"issue":"11","key":"7677_CR23","doi-asserted-by":"publisher","DOI":"10.1590\/s0102-865020190110000004","volume":"34","author":"Y Bai","year":"2019","unstructured":"Bai Y, Li Z, Liu W, et al. Biochanin A attenuates myocardial ischemia\/reperfusion injury through the TLR4\/NF-kappaB\/NLRP3 signaling pathway. Acta Cir Bras. 2019;34(11):e201901104. https:\/\/doi.org\/10.1590\/s0102-865020190110000004","journal-title":"Acta Cir Bras"},{"issue":"1","key":"7677_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/1871525718666200206114304","volume":"18","author":"S Govindasami","year":"2020","unstructured":"Govindasami S, Uddandrao VVS, Raveendran N, Sasikumar V. Therapeutic potential of biochanin-A against isoproterenol-induced myocardial infarction in rats. Cardiovasc Hematol Agents Med Chem. 2020;18(1):31\u20136. https:\/\/doi.org\/10.2174\/1871525718666200206114304","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"7677_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116002","volume":"170","author":"Z Feng","year":"2024","unstructured":"Feng Z, Zhang N, Bai J, et al. Biochanin A inhibits cardiac hypertrophy and fibrosis in vivo and in vitro. Biomed Pharmacother. 2024;170:116002. https:\/\/doi.org\/10.1016\/j.biopha.2023.116002","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"7677_CR26","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1093\/cvr\/cvab248","volume":"118","author":"G Li","year":"2022","unstructured":"Li G, Shao Y, Guo HC, et al. MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling. Cardiovasc Res. 2022;118(9):2139\u201351. https:\/\/doi.org\/10.1093\/cvr\/cvab248","journal-title":"Cardiovasc Res"},{"key":"7677_CR27","doi-asserted-by":"publisher","unstructured":"Tang J, Tu S, Lin G et al. Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia. J Exp Med. 2020;217(4). https:\/\/doi.org\/10.1084\/jem.20182091","DOI":"10.1084\/jem.20182091"},{"key":"7677_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109711","volume":"115","author":"RM El-Sayed","year":"2023","unstructured":"El-Sayed RM, Fawzy MN, Zaki HF, Abd El-Haleim EA. Neuroprotection impact of biochanin A against pentylenetetrazol-kindled mice: targeting NLRP3 inflammasome\/TXNIP pathway and autophagy modulation. Int Immunopharmacol. 2023;115: 109711. https:\/\/doi.org\/10.1016\/j.intimp.2023.109711","journal-title":"Int Immunopharmacol"},{"key":"7677_CR29","doi-asserted-by":"publisher","unstructured":"Anuranjana PV, Beegum F, K PD et al. Mechanisms behind the pharmacological application of biochanin-A: a review. F1000Res. 2023;12:107. https:\/\/doi.org\/10.12688\/f1000research.126059.3.","DOI":"10.12688\/f1000research.126059.3"},{"issue":"3","key":"7677_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202100591","volume":"19","author":"MJ Oza","year":"2022","unstructured":"Oza MJ, Kulkarni YA. Biochanin A attenuates cardiomyopathy in type 2 diabetic rats by increasing SIRT1 expression and reducing oxidative stress. Chem Biodivers. 2022;19(3):e202100591. https:\/\/doi.org\/10.1002\/cbdv.202100591","journal-title":"Chem Biodivers"},{"key":"7677_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154047","volume":"100","author":"F Luan","year":"2022","unstructured":"Luan F, Rao Z, Peng L, et al. Cinnamic acid preserves against myocardial ischemia\/reperfusion injury via suppression of NLRP3\/Caspase-1\/GSDMD signaling pathway. Phytomedicine. 2022;100: 154047. https:\/\/doi.org\/10.1016\/j.phymed.2022.154047","journal-title":"Phytomedicine"},{"key":"7677_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.897815","volume":"9","author":"X Chen","year":"2022","unstructured":"Chen X, Tian PC, Wang K, Wang M, Wang K. Pyroptosis: role and mechanisms in cardiovascular disease. Front Cardiovasc Med. 2022;9:897815. https:\/\/doi.org\/10.3389\/fcvm.2022.897815.","journal-title":"Front Cardiovasc Med"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07677-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-025-07677-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07677-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T10:58:31Z","timestamp":1770202711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-025-07677-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7677"],"URL":"https:\/\/doi.org\/10.1007\/s10557-025-07677-2","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"16 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments involved in this subject were approved and agreed by the Ethics Committee of Harbin Medical University-Daqing (HMUDQ20240725001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Authors give full consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no conflicts of interest to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}